Putting drug abuse research to use in real-life settings.
about
Evidence-based practices for substance use disordersContingency management in substance abuse treatment: a structured review of the evidence for its transportability.A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network.Partnerships and pathways of dissemination: the National Institute on Drug Abuse-Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network.Effective Clinical Supervision in Substance Use Disorder Treatment Programs and Counselor Job PerformanceComparison of opiate-primary treatment seekers with and without alcohol use disorder.What Influences Participation in QI? A Randomized Trial of Addiction Treatment Organizations.Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.Disseminating contingency management to increase attendance in two community substance abuse treatment centers: lessons learned.Dissemination activities: a critical new role for substance abuse treatment organizations.Do therapist cultural characteristics influence the outcome of substance abuse treatment for Spanish-speaking adults?Counselor attitudes toward the use of motivational incentives in addiction treatment.Informal discussions in substance abuse treatment sessions with Spanish-speaking clients.The first decade of the National Drug Abuse Treatment Clinical Trials Network: bridging the gap between research and practice to improve drug abuse treatment.Nurse turnover in substance abuse treatment programs affiliated with the National Drug Abuse Treatment Clinical Trials Network.From Cat's Cradle to Beat the Reaper: getting evidence-based treatments into practice in spite of ourselves.Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure.Gender research in the National Institute on Drug Abuse National Treatment Clinical Trials Network: a summary of findingsGender differences in the rates and correlates of HIV risk behaviors among drug abusers.Ten take home lessons from the first 10 years of the CTN and 10 recommendations for the futureHow practice and science are balanced and blended in the NIDA Clinical Trials Network: the bidirectional process in the development of the STAGE-12 protocol as an example.Adapting the helpful responses questionnaire to assess communication skills involved in delivering contingency management: preliminary psychometrics.Treatment strategy profiles in substance use disorder treatment programs: A latent class analysisStrategies to encourage adoption in multisite clinical trials.Adoption of motivational interviewing and motivational enhancement therapy following clinical trialsNIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs.Level of analysis issues in assessing treatment beliefs in substance abuse clinics.Perceptions of the state policy environment and adoption of medications in the treatment of substance use disorders.A vision of the next generation of behavioral therapies research in the addictions.Financial factors and the implementation of medications for treating opioid use disorders.Attitudes toward the integration of smoking cessation treatment into drug abuse clinicsCommunity Providers' Impression of HIV Prevention Intervention Research in NIDA's Clinical Trials NetworkRacial/ethnic differences in the rates and correlates of HIV risk behaviors among drug abusers.Innovation adoption in substance abuse treatment: exposure, trialability, and the Clinical Trials Network.Training opioid addiction treatment providers to adopt contingency management: A prospective pilot trial of a comprehensive implementation science approach.Counselors' knowledge of the adoption of tobacco cessation medications in substance abuse treatment programs.Interest and preferences for contingency management design among addiction treatment clienteleSubstance abuse counselors' implementation of tobacco cessation guidelinesClinical supervision, emotional exhaustion, and turnover intention: a study of substance abuse treatment counselors in the Clinical Trials Network of the National Institute on Drug Abuse.Quality assurance of research protocols conducted in the community: the National Institute on Drug Abuse Clinical Trials Network experience
P2860
Q24614016-665EE207-88A0-4D4B-9515-C79B9739A27BQ30421552-B3854944-BF14-4163-9088-09DA687AB5FFQ33750845-17E1588E-901A-4D67-AD65-5EC46C9F36D6Q33793165-BC602965-49DB-4070-A64A-E07D399DA307Q33930510-AA123FF7-0175-44C0-9A59-41F88B9BE4B2Q34023147-FCC753B7-3DF3-4E47-B3BC-B83AFF0A17E6Q34037035-84669989-257D-4A74-B956-538F25E4FD9EQ34081656-9394170A-DDD7-4A67-8E28-989179B523A7Q34117740-AC7003CA-3DAB-4829-9631-5B11DBD51908Q34173327-3B93ABA5-8D81-4AFF-9DAD-7C65527AA941Q34196134-4629AFD0-B839-4320-A8AC-691300E4225BQ34222652-00C905BE-D2CE-469D-93A7-18312E8BBFF7Q34259124-45FC5421-EA57-4BC0-8C63-CC19BDDE2A21Q34363688-1CA80175-3888-4C11-BD57-8CE5BE5D5516Q34777438-7988A30E-A2C5-4160-A902-F917CBC066EAQ34896293-E851D907-4ED2-4471-80F2-6099A85A7B29Q35042742-5F57F799-BEE1-4780-BE7F-A8526C6120A5Q35178476-03AF6465-52C9-4922-AFFE-019E4C92A288Q35203629-264FE559-3D6B-4105-A208-8496B5449A45Q35598143-31C23FD3-C599-4C83-A7AB-26D3E036C0A5Q35679295-D17713BB-8370-402D-AD4C-C6ECEDDD8B7EQ35685241-FDB61458-A777-44E3-B69A-8B0B1E11D6CAQ35875486-D7869DE5-D418-4E25-973E-264BA61DF2DFQ35950120-4BF78E96-435A-452E-ADB1-DBB457E93896Q35950131-4FB0B8F5-76C8-43BF-B46B-3B7555D89B91Q35990579-AE586199-EFA1-4122-98CC-760C38A3B45CQ36047706-F66CB21C-E90D-4298-AC80-718C88DC4C52Q36192673-B6D33F9B-6A4A-4759-A925-4A95A321ACAAQ36289240-D3E7E035-FF55-4F50-8DFD-B59FA43A461BQ36381418-1F6F5756-7A7B-47ED-B3D0-9AC90D74D20BQ36393932-41D2E130-28F1-4D31-85A6-DE3DFAD0BFABQ36507265-1C1E5028-0089-4CDB-91ED-BE096D8DF082Q36622863-4DC8625A-B91B-42C8-BDA7-C97ECC4A552AQ36627877-47445981-6E38-4202-AEB1-6D7E6925D5E6Q36842753-1969F6D8-4C3B-459E-B523-8B74815C9434Q36914694-264CD42C-BD48-4FCD-AA3F-2F9BBE56CD57Q36927564-C4A3D0B6-0DE2-440E-811E-F87432847C69Q36966583-B7683357-DADB-4A12-A2F2-642ED3C9E5CFQ37087541-347239BE-16ED-4D1B-978A-A8D09B094F2FQ37326679-C903F046-AF5E-48BA-9526-6AA9F392BD34
P2860
Putting drug abuse research to use in real-life settings.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Putting drug abuse research to use in real-life settings.
@en
Putting drug abuse research to use in real-life settings.
@nl
type
label
Putting drug abuse research to use in real-life settings.
@en
Putting drug abuse research to use in real-life settings.
@nl
prefLabel
Putting drug abuse research to use in real-life settings.
@en
Putting drug abuse research to use in real-life settings.
@nl
P2093
P1476
Putting drug abuse research to use in real-life settings.
@en
P2093
Alan I Leshner
Glen R Hanson
P356
10.1016/S0740-5472(02)00269-6
P577
2002-09-01T00:00:00Z